Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Companion Diagnostic Technologies Market Size, Value And Growth Trends Through 2030
The market for companion diagnostic technologies has experienced rapid expansion in recent years. This market is projected to expand from $4.44 billion in 2025 to $4.97 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.0%. The historical growth in this sector is largely due to factors such as increased adoption of precision medicine, the growing incidence of cancer and other chronic conditions, a heightened need for targeted therapeutic options, an increase in molecular diagnostics research, and greater financial commitments to biomarker discovery initiatives.
The companion diagnostic technologies market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $7.89 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This projected growth during the forecast period can be largely attributed to several factors, including the increasing development of individualized treatment plans, the growing integration of AI-powered diagnostic interpretation platforms, a rising demand for non-invasive liquid biopsy diagnostics, the broadening scope of partnerships between pharmaceutical and diagnostic companies, and the increasing number of regulatory clearances for companion diagnostic assays. Key trends expected during this period involve the greater embrace of biomarker-driven targeted therapy selection, a surging demand for next-generation sequencing companion diagnostics, wider utilization of liquid biopsy testing solutions, the expansion of personalized approaches in oncology treatment, and the increased incorporation of multiplex molecular diagnostic testing.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample_request?id=66625257&type=smp
#Companion Diagnostic Technologies Market Growth Factors: Which Forces Are Supporting Market Expansion?
The growing need for targeted therapies is anticipated to stimulate the expansion of the companion diagnostic technologies market moving forward. Targeted therapies represent a type of medical intervention employing drugs or other compounds to precisely locate and attack specific cancer cells or molecular targets, thereby limiting harm to healthy cells. The heightened interest in targeted therapies stems from their capacity to precisely target disease-specific pathways, leading to enhanced effectiveness with reduced adverse effects. Companion diagnostic technologies play a crucial role in supporting targeted therapies by facilitating the detection of particular genetic mutations, biomarkers, and molecular profiles, which in turn assists in choosing the most effective targeted treatment for individual patients, boosting treatment precision, and refining clinical decisions in oncology and other medical domains. As an illustration, in July 2023, data from a report issued by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, indicated that while there were 247 gene therapies in Phase II at the close of the first quarter (Q1) 2023, this figure saw a 5% increase to reach 260 by the end of the second quarter (Q2). Consequently, the escalating demand for targeted therapies is propelling the growth of the companion diagnostic technologies market.
Companion Diagnostic Technologies Market Segment Analysis Highlighting Growth Areas
The companion diagnostic technologies market covered in this report is segmented –
1) By Type: Immunohistochemistry, Molecular Diagnostics
2) By Sample Type: Tissue, Blood, Saliva, Other Sample Types
3) By Technology: Polymerase Chain Reaction, Next Generation Sequencing, Immunohistochemistry, In Situ Hybridization, Microarrays, Liquid Biopsy
4) By Distribution Channel: Direct Sales, Distributors
5) By Application: Oncology, Cardiovascular, Central Nervous System, Autoimmune And Inflammation, Virology, Other Applications
Subsegments:
1) By Immunohistochemistry: Antibody Based Staining Techniques, Chromogenic Detection Methods, Fluorescent Detection Methods
2) By Molecular Diagnostics: Deoxyribonucleic Acid Based Testing, Ribonucleic Acid Based Testing, Protein Biomarker Analysis
Companion Diagnostic Technologies Market Industry Trends: What Changes Are Reshaping Demand?
Leading companies in the companion diagnostic technologies market are concentrating on developing advanced genomic testing solutions, such as liquid biopsy-based companion diagnostics, to advance precision medicine, enhance targeted therapy selection, and enable more accurate cancer treatment decisions. Liquid biopsy-based companion diagnostics are blood- or fluid-based tests used to detect specific biomarkers that guide and match patients to appropriate targeted therapies. For instance, in October 2024, Foundation Medicine, Inc., a US-based molecular information company, announced the Food and Drug Administration (FDA) approved its Liquid CDx test in combination with Itovebi, strengthening its role in precision oncology diagnostics. This solution is designed to assist doctors in selecting improved treatments and making clinical decisions by utilizing a comprehensive gene-panel blood test, which helps in identifying important mutations and directing cancer treatments more effectively.
Companion Diagnostic Technologies Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the companion diagnostic technologies market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Becton Dickinson and Company, BioGenex Laboratories Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Shimadzu Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Caris Life Sciences Inc., Myriad Genetics Inc., Servier Laboratories, Pillar Biosciences Inc., EntroGen Inc.
Access The Complete Companion Diagnostic Technologies Market Report:
https://www.thebusinessresearchcompany.com/report/companion-diagnostic-technologies-market-report
Companion Diagnostic Technologies Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the companion diagnostic technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the companion diagnostic technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.